| Literature DB >> 31892850 |
Ghulam Hussain1, Jing Wang2, Azhar Rasul3, Haseeb Anwar1, Muhammad Qasim4, Shamaila Zafar1, Nimra Aziz1, Aroona Razzaq1, Rashad Hussain5, Jose-Luis Gonzalez de Aguilar6,7, Tao Sun2.
Abstract
Peripheral nerve injury is a complex condition with a variety of signs and symptoms such as numbness, tingling, jabbing, throbbing, burning or sharp pain. Peripheral nerves are fragile in nature and can easily get damaged due to acute compression or trauma which may lead to the sensory and motor functions deficits and even lifelong disability. After lesion, the neuronal cell body becomes disconnected from the axon's distal portion to the injury site leading to the axonal degeneration and dismantlement of neuromuscular junctions of targeted muscles. In spite of extensive research on this aspect, complete functional recovery still remains a challenge to be resolved. This review highlights detailed pathophysiological events after an injury to a peripheral nerve and the associated factors that can either hinder or promote the regenerative machinery. In addition, it throws light on the available therapeutic strategies including supporting therapies, surgical and non-surgical interventions to ameliorate the axonal regeneration, neuronal survival, and reinnervation of peripheral targets. Despite the availability of various treatment options, we are still lacking the optimal treatments for a perfect and complete functional regain. The need for the present age is to discover or design such potent compounds that would be able to execute the complete functional retrieval. In this regard, plant-derived compounds are getting more attention and several recent reports validate their remedial effects. A plethora of plants and plant-derived phytochemicals have been suggested with curative effects against a number of diseases in general and neuronal injury in particular. They can be a ray of hope for the suffering individuals. © The author(s).Entities:
Keywords: Non-surgical intervention; Pathophysiology; Peripheral Nerve Injury; Plant-derived compounds; Surgical interventions
Mesh:
Year: 2020 PMID: 31892850 PMCID: PMC6930373 DOI: 10.7150/ijbs.35653
Source DB: PubMed Journal: Int J Biol Sci ISSN: 1449-2288 Impact factor: 6.580
Seddon's Classification - General Features
| Neuropraxia | Axonotmesis | Neurotmesis |
|---|---|---|
| There is an occurrence of paralysis but the peripheral degradation is absent | The second grade of injury is axonotmesis in which the nerve fibers get severely damaged and leads to the intact peripheral deterioration | The 3rd grade of nerve injury is neurotmesis which results in the injury of neural connective tissue constituents and effects perineurium epineurium, and/or endoneurium. The nerve fiber is entirely divided into two ends and leads towards whole paralysis |
Seddon and Sunderland classification of nerve injuries
| Seddon classification | Neuropraxia | Axonotmesis | Axonotmesis | Axonotmesis | Neurotmesis | |
|---|---|---|---|---|---|---|
| Sunderland classification | Grade 1 | Grade 2 | Grade 3 | Grade 4 | Grade 5 | Grade 6 |
| Causes | Local ischemia, traction, mild crush, compression | Nerve crush | Nerve crush | Nerve crush | Nerve laceration and transection | Stab or gunshot wounds, closed traction damage |
| Recovery | Complete - hours up to a few weeks | Complete - weeks to months | Incomplete and variable - months | Incomplete and variable - depending on injury andtreatment - months to years | Incomplete - months to years | Incomplete - months to years |
| Pathophysiology | Connective tissues and axons in continuity, nerve conduction block | Division of axons but all layers of connective tissues remain intact | Myelin sheath & endoneurial layer are disconnected. | Axon with myelin sheath, endoneurium | Axon with myelin sheath, endoneurium, perineurium, and epineurium disconnected | Mixed injuries, all grades involved |
| Surgical Intercessions | Typically not | Typically not | Typically not | Typically required; procedure depends upon findings | Required; Early nerve healing or reconstruction | Surgical investigation & intraoperative electro-diagnostic techniques; nerve re-construction ornerve transferring |
Figure 1Graphical representation of pathophysiology of wallerian degeneration
Factors associated with peripheral nerve regeneration
| Regeneration associated factors | Role in nerve regeneration | References |
|---|---|---|
| Activating Transcription Factor-3 (ATF-3) | The overexpression of ATF-3 promotes neurite outgrowth. | |
| SRY-box containing gene 11 (Sox11) | It promotes peripheral nerve regeneration by regulating the factors essential for neuronal survival and neurite outgrowth. | |
| c-Jun | It appears to increase the expression of other regeneration associated genes (RAGs) and in that way may promote a growth state. Moreover, it is important for the activation of the nerve repairing program and its absence leads to the inactivation of significant several cell surface proteins and trophic factors which sustain the survival and axonal growth. | |
| Small proline-repeat protein 1A (SPRR1A) | It is undetectable in the uninjured neuron but its expression increase by 60-folds after damage to the peripheral axon. It is a substantial contributor to the effective nerve regeneration, hence its reduction restricts the axonal outgrowth. | |
| Growth-associated protein-43 (GAP-43) | It is a marker for neural regeneration and outgrowth. Its overexpression results in the spontaneous new synapses formation and increased sprouting after nerve injury | |
| Agrin protein | It is a nerve derivative protein, secreted by motor neurons into the synaptic cleft. It forms the AChRs clusters on the emergent skeletal muscle fiber that may assist as a target for the innervating motor neurons. It acts through the muscle-specific tyrosine kinase (MuSK) initiating the signaling pathway leading to the rapsyn-reliant AChR clustering. It also promotes the development of filopodia on neurites by increasing the number and stability of these filopodia. | |
| S100 protein | It promotes the proliferation of Schwann cells significant in neural regeneration. S100B protein expresses in Schwann cells upon the acute peripheral injury to the nerve which is released by the Schwann cells in injured nerves stimulates RAGE in infiltrating macrophages and in the activated Schwann cells. Moreover, the S100B activated RAGE endorses the migration of Schwann cells by activation of p38, NF-κB, CREB, and MAPK. | |
| CCAAT/enhancer binding protein delta (C/EBPd) and C/EBP-like transcription factor genes | They are found to be up-regulated abruptly after nerve injury. They are involved in the lipid metabolism regulation and activation of macrophage. | |
| Nerve growth factor (NGF), Fibroblast growth factor (FGF), Ciliary neurotrophic factor (CNTF), Interleukin-like growth factor (IGF), Vascular endothelial growth factor (VEGF), and Brain-derived neurotrophic factor (BDNF) | The expression of a large number of neurotropic factors/growth factors increased in Schwann cells of the distal stump after nerve injury. These neurotropic factors are released by the Bands of Bungner's that support the neuronal survival and promote remyelination. | |
| Surface cell adhesion molecules (CAMs), including L2/HNK-1, Ng-CAM/L1, N-CAM, and N-cadherin | The production of these factors enhanced by the surviving Schwann cells to promote nerve regeneration/ remyelination. | |
| Tenascin, heparan sulphate proteoglycans (HSP), fibronectin (FN), and laminin (LN) | These are the extracellular matrix proteins found in the basement membrane of Schwann cells promoting remyelination. |
Figure 2Types of surgical and non-surgical intrusions against peripheral nerve injury
Figure 3Surgical interventions for peripheral nerve repair
Figure 4Available medications for nerve pain
Figure 5Phytochemicals and their role in peripheral nerve ingury
Remedial approaches to promote nerve recovery
| Remedies | Activity | References |
|---|---|---|
| 4-Aminopyridine | Promotes remyelination | |
| Quercetin | Anti-inflammatory, antioxidant & neuroprotective. | |
| Ursolic acid | Antioxidant, antimicrobial, anti-inflammatory, hepatoprotective, immune-modulatory, anti-tumor, chemopreventive, cardioprotective, anti-hyperlipidemic and hypoglycemic. | |
| Curcumin | Manages metabolic syndromes, arthritis, anxiety, oxidative stress, inflammatory situations. Enhances the expression of S100. | |
| 7,8-dihydroxycoumarin | Antimitotic, immune-modulating, antiviral, anticancer and cytotoxic effects. | |
| Red propolis | Anti-inflammatory and anti-oxidant activities. | |
| Lycium babarum | Anti-oxidant. | |
| Tacrolimus | Increased average axon diameter, myelinated nerve fiber density and myelin sheath thickness. | |
| Improve neurite outgrowth & axonal regeneration. | ||
| Hericiumerinaceus Mushroom | Re-innervation of the neuromuscular junction. | |
| Lumbricus Extract | Improves nerve regeneration, functional recovery, and nerve conduction velocity | |
| Fermented soybean | Promote nerve regeneration by increasing TNF-α and decreasing apoptosis | |
| Valproic acid (VPA) | Anti-epileptic & mood stabilizing agent. | |
| Radix Hedysari | Neuronal regeneration. |